1935. COVID-19 mRNA Vaccination Reduces the Occurrence of Post-COVID Conditions in U.S. Children Aged 5-17 Years Following Omicron SARS-CoV-2 Infection, July 2021-September 2022

BACKGROUND: An estimated 1-3% of children with SARS-CoV-2 infection will develop Post-COVID Conditions (PCC). This study evaluates mRNA COVID-19 vaccine impact on likelihood of PCC in children. METHODS: A multi-site cohort of children enrolled 7/21/2021-9/1/2022 underwent weekly SARS-CoV-2 screening...

Descripción completa

Detalles Bibliográficos
Autores principales: Yousaf, Anna R, Mak, Josephine, Gwynn, Lisa, Bloodworth, Robin, Rai, Ramona, Jeddy, Zuha, LeClair, Lindsay B, Edwards, Laura, Olsho, Lauren E W, Newes-Adeyi, Gabriella, Dalton, Alexandra F, Gaglani, Manjusha, Yoon, Sarang K, Hegmann, Kurt, Ellingson, Katherine, Feldstein, Leora R, Campbell, Angela P, Britton, Amadea, Saydah, Sharon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678185/
http://dx.doi.org/10.1093/ofid/ofad500.2466

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678185/
http://dx.doi.org/10.1093/ofid/ofad500.2466

Ejemplares similares